Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (ACHC) and Ascendis Pharma (ASND)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Acadia Healthcare (ACHC – Research Report) and Ascendis Pharma (ASND – Research Report).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Acadia Healthcare (ACHC)
In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on Acadia Healthcare, with a price target of $14.00. The company’s shares closed last Tuesday at $14.24.
According to TipRanks.com, CFA is a 1-star analyst with an average return of
Currently, the analyst consensus on Acadia Healthcare is a Moderate Buy with an average price target of $19.09, a 55.0% upside from current levels. In a report issued on January 14, TipRanks – OpenAI also reiterated a Hold rating on the stock with a $14.00 price target.
See the top stocks recommended by analysts >>
Ascendis Pharma (ASND)
In a report released yesterday, Gavin Clark-Gartner from Evercore ISI maintained a Buy rating on Ascendis Pharma, with a price target of $317.00. The company’s shares closed last Tuesday at $215.58.
According to TipRanks.com, Clark-Gartner is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Ascendis Pharma with a $269.91 average price target, representing a 32.6% upside. In a report issued on January 11, Cantor Fitzgerald also maintained a Buy rating on the stock with a $254.00 price target.
